Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 166.81M P/E - EPS this Y 41.10% Ern Qtrly Grth -
Income -111.08M Forward P/E -2.62 EPS next Y 41.10% 50D Avg Chg -1.00%
Sales 11M PEG 0.00 EPS past 5Y - 200D Avg Chg -58.00%
Dividend N/A Price/Book 1.22 EPS next 5Y 110.70% 52W High Chg -76.00%
Recommedations 3.00 Quick Ratio 4.20 Shares Outstanding 54.85M 52W Low Chg 20.00%
Insider Own 15.75% ROA -63.43% Shares Float 46.78M Beta 0.70
Inst Own 32.74% ROE -184.32% Shares Shorted/Prior 1.11M/842.93K Price 3.09
Gross Margin - Profit Margin - Avg. Volume 1,429,196 Target Price 1.00
Oper. Margin -1,636.13% Earnings Date Nov 11 Volume 386,952 Change -1.59%
About Cara Therapeutics, Inc.

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

Cara Therapeutics, Inc. News
08/15/24 Cara: Q2 Earnings Snapshot
07/11/24 Cara Therapeutics Announces Exploration of Strategic Alternatives
06/13/24 Chipotle, McDonald's initiated: Wall Street's top analyst calls
06/12/24 Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
05/13/24 Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
05/13/24 Cara Therapeutics Reports First Quarter 2024 Financial Results
05/06/24 Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
04/02/24 Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
03/07/24 Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
03/07/24 7 F-Rated Stocks to Sell in March 2024
03/07/24 Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report
03/06/24 Cara Therapeutics Full Year 2023 Earnings: Misses Expectations
03/05/24 Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
03/05/24 Q4 2023 Cara Therapeutics Inc Earnings Call
03/04/24 Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
03/04/24 Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
02/21/24 We're A Little Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate
02/12/24 Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
01/22/24 Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
12/19/23 CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%
CARA Chatroom

User Image PenkeTrading Posted - 2 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Cara Therapeutic. Is that bullish or bearish? $CARA #RsiOversold #NASDAQ

User Image ViktorSinclair Posted - 1 week ago

$CARA looks like delisting is in process. it is well below a buck now coming on 6 months and there is little hope and zero comments from management.

User Image PotPotMan420 Posted - 08/29/24

$CARA in for a rip

User Image liadanielle Posted - 08/27/24

$CARA Might buy 1000 shares for my great great great grandchildren

User Image StockConsultant Posted - 08/26/24

$CARA Therapeutics stock, strong close, watch for a narrow range breakout above 0.396, volume +55% at https://stockconsultant.com/?CARA

User Image PapaRoki Posted - 08/24/24

$CARA they were ready on that big volume from 7-11 get ready

User Image Estimize Posted - 08/18/24

$CARA misses the Estimize EPS Consensus by 7c and the Estimize Revenue Consensus by $0.25M. Reports FQ2 earnings of -37c EPS and $0.99M... http://www.estimize.com/cara/fq2-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image ViktorSinclair Posted - 1 month ago

$CARA

User Image Hbogati Posted - 1 month ago

$CARA Quaterly filling is out, no press release. What would be the most realistic outcome here? Are there any big institutions owning that can force the Board out?

User Image lonedaddy Posted - 1 month ago

$CARA the clown show continues.... 2 months and they still don't know what to do.

User Image NVDAMillionaire Posted - 07/30/24

$CARA Cara Therapeutics Navigates Challenging Landscape, Focuses on Promising Notalgia Paresthetica Program http://beyondspx.com/2024/07/30/cara-therapeutics-navigates-challenging-landscape-focuses-on-promising-notalgia-paresthetica-program/

User Image Iamthecooler Posted - 07/30/24

$CARA laid off 70% of workers. Fuck Cara

User Image BWUSAF Posted - 07/29/24

@Marketslive - 3 alerts to me this am that my tickers have yet again, hit new 52 week lows $atom, $cue and $cara. all highly prospective micros.... but, come on. This is a bs market and guarantee the 401k's most have, have very few of the tickers that ran to ath (or VERY small %), that don't move their accts. much and refuse to allow employees to buy the actual stock vs. limited Van. Mutual/Bond funds - rigged game when they created 401k's. #sheeplewerebornwiththe401k

User Image StockConsultant Posted - 07/26/24

$CARA Therapeutics stock breakout at https://stockconsultant.com/?CARA

User Image lonedaddy Posted - 07/23/24

$CARA Hope these clowns do a better job strategizing than the piss poor job they did for their product line and product launch strategy.

User Image iEnvest Posted - 07/23/24

Need this to push up more $CARA

User Image ViktorSinclair Posted - 07/22/24

$CARA another leg down is coming… brace yourself

User Image HScottMatusow Posted - 07/18/24

@Chiefsittingpug @AnalRetort And I'll leave you with this "Landtank," If u took $CARA, u would have won. The pinch confirmed (u prob don't know what that is), and took $PACB at $1.63, which hit $2.24 2 days later. Now, I know losers love when a person fails - stop being a loser man.

User Image Iamthecooler Posted - 07/17/24

$CARA I should have bought coke, made rock and gone to prison, still be ahead nikka

User Image eyeownu Posted - 1 month ago

$CARA she's flagging

User Image OffComesTheShirt Posted - 2 months ago

$CARA 10% Off Comes The Shirt

User Image getoverhere Posted - 2 months ago

$CARA Still holding trend would like to see a move back up soon

User Image Fullratio Posted - 2 months ago

$CARA EV/Sales is 93% less than its 5-year quarterly average of 14.6 and 55% less than its last 4 quarters average of 2.4: https://fullratio.com/stocks/nasdaq-cara/cara-therapeutics

User Image HScottMatusow Posted - 2 months ago

@LandTank @biosleuth $CARA hit 41 cents, from my entry of 30.5, so we all made money Bo. Got that in before i perma ban you. Don't come back to room ever.

User Image Buckwacker Posted - 2 months ago

$CARA still junk I see…

User Image Sarah_0032 Posted - 2 months ago

$CARA

User Image Alaa2531981 Posted - 2 months ago

$CARA

User Image Str8ToTheMoon Posted - 2 months ago

$CARA x² ez 😎

User Image PapaRoki Posted - 2 months ago

$CARA shaved 🪒 booty baby

User Image SupremeTrader93 Posted - 2 months ago

$MAXN 🔥🔥🐂🐂 $RNLX $SNOA $CARA

Analyst Ratings
Canaccord Genuity Hold Jun 13, 24
HC Wainwright & Co. Neutral Jun 13, 24
Needham Hold Jun 13, 24
Needham Buy May 23, 24
HC Wainwright & Co. Buy May 15, 24
Needham Buy May 14, 24
Needham Buy Apr 10, 24
Canaccord Genuity Buy Mar 6, 24
Needham Buy Mar 5, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Posner Christopher President and CEO President and CEO Aug 03 Sell 3.07 4,307 13,222 168,207 08/04/23
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Apr 04 Sell 4.91 2,481 12,182 91,046 04/06/23
Goncalves Joana Chief Medical Office.. Chief Medical Officer Apr 04 Sell 4.91 2,481 12,182 56,404 04/06/23
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Apr 04 Sell 4.91 2,733 13,419 156,740 04/06/23
Posner Christopher President and CEO President and CEO Feb 02 Sell 11.80 4,191 49,454 182,370 02/03/23
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Dec 21 Sell 11.27 3,506 39,513 166,275 12/23/22
Goncalves Joana Chief Medical Office.. Chief Medical Officer Dec 21 Sell 11.27 2,992 33,720 71,901 12/23/22
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Dec 21 Sell 11.27 2,561 28,862 99,783 12/23/22
Ives Jeffrey L. Director Director Jul 15 Sell 9.05 3,600 32,580 15,476 07/19/22
BAINS HARRISON M JR Director Director Jul 15 Sell 9.05 7,200 65,160 25,076 07/19/22
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Apr 01 Sell 11.91 1,642 19,556 102,344 04/05/22
Goncalves Joana Chief Medical Office.. Chief Medical Officer Apr 01 Sell 11.91 1,642 19,556 74,893 04/05/22
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Apr 01 Sell 11.91 1,784 21,247 169,781 04/05/22
Posner Christopher President and CEO President and CEO Apr 04 Sell 12.67 2,006 25,416 201,031 04/05/22
Reilly Thomas Charles Chief Financial Offi.. Chief Financial Officer Mar 03 Sell 11.38 2,044 23,261 37,811 03/04/22
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Mar 03 Sell 11.38 1,787 20,336 103,986 03/04/22
Posner Christopher Director Director Jun 07 Sell 13.04 2,304 30,044 16,096 06/07/21
Ives Jeffrey L. Director Director Jun 07 Sell 13.05 2,520 32,886 15,380 06/07/21
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Mar 08 Sell 17.98 3,358 60,377 119,319 03/08/21
CHALMERS DEREK T President & CEO President & CEO Mar 08 Sell 17.98 3,103 55,792 950,511 03/08/21
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Feb 25 Sell 19.33 4,004 77,397 44,432 02/25/21
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Feb 25 Sell 19.33 5,003 96,708 112,677 02/25/21
Goncalves Joana Chief Medical Office.. Chief Medical Officer Feb 25 Sell 19.33 3,372 65,181 26,703 02/25/21
CHALMERS DEREK T President & CEO President & CEO Feb 25 Sell 19.33 11,729 226,722 943,614 02/25/21
CHALMERS DEREK T President & CEO President & CEO Dec 29 Sell 16 5,000 80,000 942,671 12/29/20